Stock listing
A2JLMD Stock Price, News, Filings & Events — Amneal Pharmaceuticals, Inc.
Selected listing: A2JLMD · LS · EUR · DE
This page tracks Amneal Pharmaceuticals, Inc.'s A2JLMD:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JLMD:LS. A2JLMD:LS is the stock-level entry point for investors researching Amneal Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Amneal Pharmaceuticals, Inc. (ticker: AMRX) is a public company operating in the American market. With a market capitalization of approximately $5.72 billion, Amneal focuses on developing and manufacturing generic and specialty pharmaceuticals. The company aims to provide high-quality, affordable medications to improve patient access and health outcomes.
- Ticker
- A2JLMD:LS
- Asset type
- Stock
- Market cap
- $5.72B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Amneal Pharmaceuticals, Inc. A2JLMD:LS stock context
This page tracks Amneal Pharmaceuticals, Inc.'s A2JLMD:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2JLMD:LS. A2JLMD:LS is the stock-level entry point for investors researching Amneal Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Amneal Pharmaceuticals, Inc. (ticker: AMRX) is a public company operating in the American market. With a market capitalization of approximately $5.72 billion, Amneal focuses on developing and manufacturing generic and specialty pharmaceuticals. The company aims to provide high-quality, affordable medications to improve patient access and health outcomes.
Latest news from Amneal Pharmaceuticals, Inc.
Amneal Reports Second Quarter 2026 Financial Results
July 30, 2026
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
July 17, 2026
Amneal to Report Second Quarter 2026 Results on July 30, 2026
July 9, 2026
Dispensary of Hope Launches "Hope Alliance" Campaign with Support from Amneal Pharmaceuticals
June 10, 2026
Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkin...
June 5, 2026
Amneal Pharmaceuticals, Inc. earnings calls
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2026 Earnings Call
May 1, 2026 · Replay with transcript and chapters
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2025 Earnings Call
February 27, 2026 · Replay with transcript and chapters
Amneal Pharmaceuticals, Inc. (AMRX) Q3 2025 Earnings Call
October 30, 2025 · Replay with transcript and chapters
Amneal Pharmaceuticals, Inc. (AMRX) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2025 Earnings Call
May 2, 2025 · Replay with transcript and chapters
Research Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for A2JLMD:LS.
Amneal Pharmaceuticals, Inc. company profile
View the public company page for Amneal Pharmaceuticals, Inc. on 6ix.
Amneal Pharmaceuticals, Inc. news
Read company news and market updates connected to Amneal Pharmaceuticals, Inc..
Amneal Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Amneal Pharmaceuticals, Inc..
Alternate listings
AMRX:NASDAQ
US · USD
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
2DT:GETTEX
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
A2JLMD:LSX
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
2DT:TRADEGATE
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
AMRX:BOATS
US · USD
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
2DT:FWB
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
2DT:DUS
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
2DT:MUN
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.
2DT:SWB
DE · EUR
Alternate listing for Amneal Pharmaceuticals, Inc.; the primary context on this page is A2JLMD:LS.